Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingxing Zang

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Genes & Diseases|December 29, 2018
2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade - A personal accountXingxing Zang
Advances in Experimental Medicine and Biology|October 20, 2019
Structures of Immune Checkpoints: An Overview on the CD28-B7 FamilyWeifeng Liu, Xingxing Zang
The Journal of Clinical Investigation|October 4, 2006
To be or not to be B7Xingxing Zang, James P Allison
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The B7 family and cancer therapy: costimulation and coinhibitionXingxing Zang, James P Allison
Cell Metabolism|July 4, 2019
Tumor Cholesterol Up, T Cells DownElodie Picarda, Xiaoxin Ren, Xingxing Zang
Discovery Medicine|September 1, 2011
T cell costimulation and coinhibition: genetics and diseaseLisa Scandiuzzi, Kaya Ghosh, Xingxing Zang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy ResistancePhillip M Galbo, Xingxing Zang, Deyou Zheng
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2008
The contrasting role of B7-H3Kimberly A Hofmeyer, Anjana Ray, Xingxing Zang
STAR Protocols|November 17, 2022
Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor modelXiaoxin Ren, Devin T Corrigan, Xingxing Zang
Immunological Investigations|July 16, 2016
Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?Weifeng Liu, Steven C Almo, Xingxing Zang
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Genes & Diseases|December 29, 2018
2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade - A personal accountXingxing Zang
Advances in Experimental Medicine and Biology|October 20, 2019
Structures of Immune Checkpoints: An Overview on the CD28-B7 FamilyWeifeng Liu, Xingxing Zang
The Journal of Clinical Investigation|October 4, 2006
To be or not to be B7Xingxing Zang, James P Allison
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The B7 family and cancer therapy: costimulation and coinhibitionXingxing Zang, James P Allison
Cell Metabolism|July 4, 2019
Tumor Cholesterol Up, T Cells DownElodie Picarda, Xiaoxin Ren, Xingxing Zang
Discovery Medicine|September 1, 2011
T cell costimulation and coinhibition: genetics and diseaseLisa Scandiuzzi, Kaya Ghosh, Xingxing Zang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy ResistancePhillip M Galbo, Xingxing Zang, Deyou Zheng
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2008
The contrasting role of B7-H3Kimberly A Hofmeyer, Anjana Ray, Xingxing Zang
STAR Protocols|November 17, 2022
Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor modelXiaoxin Ren, Devin T Corrigan, Xingxing Zang
Immunological Investigations|July 16, 2016
Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?Weifeng Liu, Steven C Almo, Xingxing Zang
Pageof 12